Zavolosotine

N/A

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameZavolosotine
Drug Alias NameSST5 Agonist therapy(Crinetics)CRN0-4777CRN04777CRN-04777
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 5 agonists
TargetsSomatostatin receptor 5
Therapy Area/IndicationsCongenital Hyperinsulinism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrinetics Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCongenital Hyperinsulinism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A